Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Daiichi Sankyo strengthens US presence with Azor approval

Azor will now compete with Novartis' Exforge, a combination of amlodipine and Diovan, which was approved by the FDA in June 2007.

People, June, 2005

Zoe Healey joins from Grayling, where she worked on PR for pharma, biotech and service companies, and will work with the global Diovan team among others.

New Accounts: March

Novartis. Aclasta. CRM. MRM Worldwide. Novartis. Diovan/Codiovan. Hypertension. TVF Communications. Novartis. ... Zaicom MMC. Pfizer. Diovan/Codiovan. Hypertension. TVF Communications. Pfizer. Vfend. Haematology. Zaicom MMC.

New Accounts: April

NICE. At Ri-SK? awareness campaign. Solar keratosis. hsdcommunications. Novartis. Diovan/Codiovan. Hypertension.

New accounts: February

Pfizer. Diovan/Codiovan. Hypertension. TVF Communications. Pfizer. Injectable contraceptive. Contraception. Ruder Finn.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...